We are monitoring the impact of COVID-19 on Europe Microbiology Testing/Clinical Microbiology Market Get in touch with us for detailed analysis Know More
Share on

Europe Microbiology Testing/Clinical Microbiology Market Research Report - Segmented By Microbiology Application, Clinical Application, Product & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 7142
Pages: 145

Europe Microbiology Testing Market Size & Growth (2022 to 2027):

As per the research report, the size of the Europe Microbiology Testing/Clinical Microbiology Market is valued at USD 1.22 billion in 2022 and is projected to be growing at a CAGR of 12.20%, to touch USD 2.17 billion by 2027 during the forecast period 2022 to 2027.

Technological advancements in microbiology testing, an increase in infectious diseases and epidemic outbreaks, rising healthcare spending, and expanding private-public funding for infectious disease research contribute to the microbiology testing market's growth in Europe.

Another factor driving the microbiology testing market is the rapid expansion of the elderly population, an increase in the number of clinical research studies in the field of clinical microbiology, and increased financing, research grants, and investments.

Additionally, the main microbiology testing marketing businesses introduce novel tests. These improvements have made a beneficial impact on the European microbiological testing market demand.

Consumers in the microbiological testing market accept these testing procedures due to increased efficiency in delivering findings, which is one of the primary factors. Furthermore, monoplex testing is being replaced by multiplex testing in the microbiology testing business.

Furthermore, these two significant drivers drive expansion in the European microbiology testing market. The release of new tests by some of the industry's leading businesses is expected to impact European demand positively.

The primary goal of the microbiological testing industry should be to discover and control hazardous microorganisms that can ruin food and assure food safety.

Delayed payment is a significant impediment to market expansion in certain rural places. Microbiology testing reimbursement is a complicated procedure, and the complexity of the reimbursement process is a hurdle for this industry. In addition, the lack of standardized reimbursement procedures across countries inhibits the market's growth. As a result, market growth in emerging countries is hampered by a lack of reimbursement.

Another concern is that testing kits and devices have proven false-negative results. For example, microbial testing kits are frequently inaccurate for various reasons. The lack of accuracy in microbiology testing is expected to limit the market's growth.

This research report on the Europe Microbiology Testing/Clinical Microbiology Market has been segmented and sub-segmented into the following categories:

By Microbiology Application:

  • Pharmaceutical
  • Clinical
  • Manufacturing
  • Energy

By Clinical Application:

  • Respiratory Diseases
  • STD
  • UTI

By Product:

  • instruments
  • Analysers
  • Consumables

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the Europe holds the second position in terms of market share globally. There is potential for market growth due to the presence of some untapped markets coupled with the rising frequency of chronic ailments. Increasing private sector investments by key companies to increase R&D to expand market margins in the region are set to further set to augment market growth in the European region.

Increased technological advancements, rising funding, research grants, and corporate investments, increasing emphasis on practical and early diagnosis, increase in the number of infectious diseases, and technological advancements all influence the European region.

Infectious illnesses such as HIV, tuberculosis, malaria, and pneumonia have increased in Germany, the United Kingdom, and France. As the regional burden of these diseases grows, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and susceptibility testing against pathogens is expected to increase. In addition, growing food safety concerns are a key factor driving market expansion.

Due to increased funding for R&D, increased focus on early detection of infectious disease increased prevalence of infectious disease and cancer, and rising usage of technology and advancements that make microbiology tests faster, cheaper, and more accurate in European countries in the region, Europe is likely to have a massive demand in the forecast period.

Furthermore, the healthcare infrastructure in many developing economies is increasing, boosting the microbiological testing market even more. Consumers' increased disposable money and changing lifestyles due to unhealthy eating are influencing the microbiology testing market in Europe.

KEY MARKET PLAYERS

Key players operating in the Europe Microbiology Testing/Clinical Microbiology Market profiled in this report are Danaher Corporation , Becton, Dickinson, and Company , Cepheid  Abbott Laboratories Inc. , Bio-Rad Laboratories Inc. , F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc, Bruker Corporation , and Hologic, Inc. , among others.,

1.Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product                        

       5.1.1 Introduction           

       5.1.2 Instruments           

                       5.1.2.1 Laboratory Instruments

                       5.1.2.2 Microbiology Analyzers

       5.1.3 Reagents 

       5.1.5  Y-o-Y Growth Analysis, By Product              

       5.1.6  Market Attractiveness Analysis, By Product            

       5.1.7  Market Share Analysis, By Product              

                5.2 Application                 

       5.2.1 Introduction           

       5.2.2 Pharmaceutical     

       5.2.3 Clinical       

       5.2.4 Food Testing          

       5.2.5 Energy      

       5.2.6 Chemical and Material Manufacturing        

       5.2.7 Environmental       

       5.2.8 Y-o-Y Growth Analysis, By Application         

       5.2.9 Market Attractiveness Analysis, By Application       

       5.2.10 Market Share Analysis, By Application      

                5.3 Disease Area     

       5.3.1 Introduction           

       5.3.2 Respiratory Disseases        

       5.3.3 Bloodstream Infections     

       5.3.4 Gastrointestinal Diseases 

       5.3.5 Sexually Transmitted Diseases       

       5.3.6 Urinary Tract Infections     

       5.3.7 Periodontal Diseases          

       5.3.8 Others      

       5.3.9 Y-o-Y Growth Analysis, By Disease Area     

       5.3.10  Market Attractiveness Analysis, By Disease Area

       5.3.11  Market Share Analysis, By Disease Area 

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Product

                       6.1.3.3 By Application

                       6.1.3.4 By Disease Area

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Product

                       6.1.4.3 By Application

                       6.1.4.4 By Disease Area

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Product

                       6.1.5.3 By Application

                       6.1.5.4 By Disease Area

               6.2 U.K                 

                6.3 Spain      

                6.4 Germany                     

                6.5 Italy        

                6.6 France   

7.Strategic Analysis               

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                

                8.1 Biomerieux S.A.                        

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Danaher Corporation    

                8.3 Becton, Dickinson and Company                       

                8.4 Cepheid (U.S.)

                8.5 Abbott Laboratories, Inc.                      

                8.6 Alere, Inc.                   

                8.7 Bio-Rad Laboratories Inc                       

                8.8 F. Hoffman-LA Roche Ltd.                    

                8.9 Hologic Inc                  

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables                

                b) List of Figures     

  1. Europe Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  2. Europe Instruments Market By Region, From 2022 - 2027 ( USD Billion )
  3. Europe Reagents Market By Region, From 2022 - 2027 ( USD Billion )
  4. Europe Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  5. Europe Pharmaceutical Market By Region, From 2022 - 2027 ( USD Billion )
  6. Europe Clinical Market By Region, From 2022 - 2027 ( USD Billion )
  7. Europe Food Testing Market By Region, From 2022 - 2027 ( USD Billion )
  8. Europe Energy Market By Region, From 2022 - 2027 ( USD Billion )
  9. Europe Chemical and Material Manufacturing Market By Region, From 2022 - 2027 ( USD Billion )
  10. Europe Environmental Market By Region, From 2022 - 2027 ( USD Billion )
  11. Europe Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )
  12. Europe Respiratory Diseases Market By Region, From 2022 - 2027 ( USD Billion )
  13. Europe Bloodstream Infections Market By Region, From 2022 - 2027 ( USD Billion )
  14. Europe Gastrointestinal Diseases Market By Region, From 2022 - 2027 ( USD Billion )
  15. Europe STD Market By Region, From 2022 - 2027 ( USD Billion )
  16. Europe UTI Market By Region, From 2022 - 2027 ( USD Billion )
  17. Europe Periodontal Diseases Market By Region, From 2022 - 2027 ( USD Billion )
  18. Europe Others Market By Region, From 2022 - 2027 ( USD Billion )
  19. U.K. Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  20. U.K. Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  21. U.K. Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )
  22. Germany Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  23. Germany Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  24. Germany Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )
  25. France Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  26. France Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  27. France Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )
  28. Italy Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  29. Italy Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  30. Italy Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )
  31. Spain Microbiology Testing/Clinical Testing Market By Product, From 2022 - 2027 ( USD Billion )
  32. Spain Microbiology Testing/Clinical Testing Market By Application, From 2022 - 2027 ( USD Billion )
  33. Spain Microbiology Testing/Clinical Testing Market By Disease Area, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample